HOME >> MEDICINE >> NEWS
Emory School of Medicine receives $16 million NIH grant to lead biodefense consortium

Emory University School of Medicine has received a grant of $16 million to lead one of five national Cooperative Centers for Translational Research on Human Immunology and Biodefense announced today by the National Institute of Allergy and Infectious Diseases (NIAID). Other institutions in the Emory center include the Institute for Systems Biology in Seattle, Washington; the Institute for Research in Biomedicine in Bellinzona, Switzerland, the Mayo Clinic, and the Centers for Disease Control and Prevention (CDC).

The four-and-a-half year grant is part of $85 million in NIAID awards aimed at a better understanding of the human immune response to potential agents of bioterror and rapid development of counter measures such as vaccines and therapies. The translational centers will focus on moving new findings about immune system function out of the laboratory and into clinical trials.

The Emory-led projects will include studying the human immune response to a vaccine in its entirety, from innate responses to peak immune responses, to the development of long-term immune memory; understanding how a successful vaccine works and using that knowledge to design strategies to enhance vaccine efficacy; and understanding at a cellular level how vaccines lose their effectiveness over time so as to improve the responses of the elderly to vaccination.

Scientists in the Emory consortium will use genomics and proteomics to study the molecular signatures of vaccine-induced innate and adaptive immune responses, says Rafi Ahmed, PhD, director of the Emory Vaccine Center, a Georgia Research Alliance Eminent Scholar, and principal investigator of the Emory grant. "These molecular 'signatures' will help us differentiate between 'good' and 'bad' vaccines," Dr. Ahmed explains. "And this knowledge should allow us to manipulate these immune responses to either enhance immunity in the case of vaccines and immune therapy or to decrease immune responses in autoimmune disease
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
17-Sep-2003


Page: 1 2

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory conference to educate health professionals about metabolic syndrome
5. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
6. Emory researchers find race and gender gaps in treatment of heart attack
7. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
8. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
9. Emory scientists find marker for long-term immunity
10. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
11. Emory scientists link atrial fibrillation with decrease in nitrous oxide

Post Your Comments:
(Date:7/28/2015)... ... 2015 , ... American Sentinel University has been named an ... Geisinger Health System (GHS), one of the nation’s largest integrated health services organizations. ... access to American Sentinel’s affordable, flexible and CCNE-accredited RN to BSN nursing degree ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... Education courses throughout California in the fall of 2015 . These seventeen ... Occupational Therapists. , Optimizing Functional Mobility in the Older Adult , ...
(Date:7/28/2015)... ... 28, 2015 , ... Peter Forbes, President of the Veterans Fund of the United States, managing ... the Veterans Coalition, is spearheading a campaign to help homeless Veterans by giving them “A ... and trade skills. Forbes and the UVBH assists and supports Vets through the Veterans ...
(Date:7/27/2015)... (PRWEB) , ... July 28, 2015 , ... Combination Product ... p.m. – 3:00 p.m. EDT, http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a ... makers of combination products things can get messy in a hurry. In a 46-page ...
(Date:7/27/2015)... ... ... The National Association of Professional Women (NAPW) honors Deana ... Circle. She is recognized with this prestigious distinction for leadership in healthcare. With more ... networking organization exclusively for professional women. , “I’m pleased to recognize Deana with this ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2
(Date:7/27/2015)... CTI BioPharma Corp. (NASDAQ and MTA: CTIC) ... quarter 2015 financial results on Thursday, August 6, 2015, ... the announcement, members of the management team will host ... provide a general corporate update at 4:30 p.m. EDT ... obtained as follows: Thursday, August 6 1:30 ...
(Date:7/27/2015)... and PARIS , July ...  and Sanofi have entered into a new global ... treatments in the emerging field of immuno-oncology. As part ... a programmed cell death protein 1 (PD-1) inhibitor currently ... trials in 2016 with new therapeutic candidates based on ...
(Date:7/27/2015)... and WESTLAKE VILLAGE, Calif. ... AGN ) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: ... Commission (FTC) has granted early termination of the waiting ... (HSR Act) with respect to Allergan,s pending acquisition of ... On July 6, 2015, each of Allergan ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
Cached News: